Head Start Annual Meeting

Please see below for further information and for future events.

.

Head Start Annual Meeting 2022

The fifth Head Start Annual Meeting took place on Friday 04 (eve) & Saturday 05 March 2022 at the Hilton Birmingham Metropole Hotel

This promotional meeting was organised and funded by Teva UK Limited and was open to Consultants, Nurses, GPs and other healthcare professionals from the UK and Ireland with an interest in headache and migraine.

The agenda was formulated by a Steering Committee of headache and migraine specialists, with engaging sessions and expert speakers.

This meeting was organised in accordance with England’s latest government guidance on COVID-19. All necessary safety precautions were place. 

Continuing Medical Education (CME) accreditation points will be applied for from The Federation of the Royal College of Physicians and The Royal College of Nursing.

.

Steering Committee

Meeting Co-Chair

Professor Peter Goadsby, Professor of Neurology, King's College, London

Meeting Co-Chair

Dr Sarah Miller, Consultant Neurologist, Queen Elizabeth University Hospital, Glasgow

Steering Committee Member

Ms Susie Lagrata, Nurse Specialist, The National Hospital for Neurology and Neurosurgery, London

Steering Committee Member

Dr Richard Wood, GPwSI, Berkshire, Buckinghamshire & Oxfordshire LMC

.

Meeting Agenda

Friday 04 March 2022

toggle more information
Time Session Speaker 
16:00-17:00 Meeting registration, networking, and refreshments
17:00-17:15 Co-Chair’s welcome Professor Peter Goadsby, Professor of Neurology, King’s College London

The ‘not so common’ headache disorders
Chaired by Dr Sarah Miller, Consultant Neurologist, Queen Elizabeth University Hospital, Glasgow

17:15-17:50

Cough headache

Dr David Moreno, Clinical Research Fellow, King’s College London
17:50-18:25 Sleep circadian rhythm Dr Alexander Nesbitt, Consultant Neurologist, Guy’s and St Thomas’ NHS Foundation Trust, London
18:25-19:00

Pressure headache

Professor Alexandra Sinclair, Professor of Neurology, The University of Birmingham

19:00-19:30

Let’s hear your thoughts Dr Sarah Miller
19:30 Co-Chair’s close Dr Sarah Miller
19:30-20:00 Drinks reception
20:00 Dinner

Saturday 05 March 2022

toggle more information
Time Session Speaker 
08:30-09:00 Meeting registration, networking, and refreshments
09:00-09:05 Co-Chair’s welcome Dr Sarah Miller

Optimising the headache service
Chaired by Dr Richard Wood, Berkshire, Buckinghamshire & Oxfordshire LMC

09:05-09:30 The changes in the NHS: what does this mean for headache? Dr Niranjanan Nirmalananthan, Consultant Neurologist, St George’s University Hospitals NHS Foundation Trust, London
09:30-09:55 Self-efficacy and self-management Dr Sophie Mitchell, Clinical Psychologist, University College London Hospitals NHS Foundation Trust
09:55-10:40 Parallel sessions A (delegates to select one workshop to attend)
1a – Empowering and educating migraine patients in Primary Care Dr Jessica Briscoe, Guy’s and St Thomas’ NHS Foundation Trust, London
2a – Complex headache cases Dr Farooq Maniyar, Consultant Neurologist, The Royal London Hospital, Barts Health NHS Trust
3a – Resilience and self-care for the HCP Dr Sophie Mitchell
10:40-11:10 Coffee break
11:10-11:45 Parallel sessions B (delegates to select one workshop to attend)

1b – Setting up a nurse-led anti-CGRP clinic

Ms Rebecca Stuckey, Clinical Nurse Specialist, University Hospitals Plymouth NHS Trust

2b – Headache for a Neurologist on-call

Dr Jane Anderson, Consultant Neurologist, Cambridge University Hospitals NHS Trust

3b – Headache at the front line

Dr David Watson, GPwSI, Hamilton Medical Group, Aberdeen

Our real-world experience of managing patients with monoclonals
Chaired by Ms Susie Lagrata, The National Hospital for Neurology and Neurosurgery, London

11:45-12:15

The Hull experience

Professor Fayyaz Ahmed, Consultant Neurologist, Hull University Teaching Hospitals NHS Trust

12:15-12:45

The Glasgow experience

Ms Lesley Murray, Lead Pharmacist for Neurosciences, Queen Elizabeth University Hospital, Glasgow

12:45-13:15

Practical implementation and stopping

Dr Brendan Davies, Consultant Neurologist, Royal Stoke University Hospital

13.15-14.15 Lunch
Afternoon discussions

14:15-14:45

What do you need vs what do I need?

Dr Sarah Miller and Ms Susie Lagrata

14:45-15:30

The future of headache

Professor Peter Goadsby, Dr Sarah Miller, Ms Susie Lagrata and Dr Richard Wood

15:30-15:45

Co-Chair’s close

Professor Peter Goadsby

.

Frequently Asked Questions

Some of the most frequently asked questions are answered below. Please click on the question to view the answer.

If you have any further questions, please do not hesitate to contact Secretariat@headstartmeeting.co.uk.

How much does this meeting cost to attend?

Toggle Expand/ Collapse

This meeting was free to attend. 

Is this meeting CME accredited?

Toggle Expand/ Collapse

CME accreditation will be applied for from The Federation of the Royal College of Physicians and from The Royal College of Nursing for this meeting. If approved, the number of CME points will be awarded after the event.

.

Contact Us

If you have a specific question about our products or services, please use the main Teva contact us information to direct your query.

If you are reporting an adverse event or side effect relating to one of our products, please contact uk.safety@tevauk.com.


Webinar: 'Optimising Headache Pathways'

This promotional meeting is organised and funded by Teva UK Limited and open to Consultants, Nurses, GPs and other healthcare professionals from the UK and Ireland with an interest in headache and migraine

Learn more Webinar: 'Optimising Headache Pathways'
Back to Head Start
Date of preparation: May 2022
Reference: MIG-GB-00071

This meeting is open to HCPs from the UK and Ireland with an interest in headache and migraine.
This promotional meeting is organised and funded by Teva UK Limited

Teva Logo--100X35.png

Teva UK Limited, Ridings Point, Whistler Drive, Castleford, West Yorkshire, WF10 5HX  +44 (0) 1977 628500 | www.tevauk.com

Ajovy®(fremanezumab) UK Prescribing Information
Ajovy®(fremanezumab) ROI Prescribing Information

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (UK) or www.hpra.ie (ROI). Adverse events should also be reported to Teva using the Reporting Side Effects Form or email uk.safety@tevauk.com.

Privacy PolicyTerms and Conditions  | AccessibilityReporting Adverse Events